EyeNet 2021 Media Kit - American Academy of Ophthalmology
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
EyeNet
®
MAGAZINE
2021
Media
Kit
EyeNet
®
MAGAZINE
EyeNet is the Academy’s official newsmaga
EyeNet EyeNet
®
®
OCTOBER 2020
zine and the premier source among the oph M AY 2020
AAO 2020 VIRTUAL: Opinion (p. 12) & Previews (p. 77) Avoid Cornea Surprises
The Gut
A Surgeon’s Guide to Genetic Disorders
and the Eye thalmic trade press of credible information
From AMD to Uveitis
for ophthalmologists. EyeNet delivers practi
cal clinical information that can be applied
GLAUCOMA EMERGENCY!
These Drugs Can Trigger
Acute-Angle Closure
immediately in patient care, plus coverage of COVID-19 Pandemic
Telemedicine to the Forefront (p 25)
Ocular Tumor Triage and Care (p 29)
Plus: Editorials by Ruth Williams (p 10)
COVID-19
and David Parke (p 13)
Physician Training During a Pandemic
MIPS 2020: The 64-Page Supplement
a broad range of subjects of interest to oph
IOL Suture Update: Keep This Reference at Your Desk
Prolene or Gore-Tex?
01_Cover_F.indd 1 4/8/20 4:11 PM
01_Cover_F.indd 1 9/9/20 5:03 PM
thalmologists, including business and news—
all in a concise, highly readable format.
Organization Affiliation EyeNet is a member benefit for American Academy
of Ophthalmology (AAO) Members and Members in
Training worldwide.
It also is a benefit for American Academy of Ophthalmic
Executives (AAOE) Members.
AAO membership includes 93% of practicing U.S. oph
thalmologists and 99% of in-training ophthalmologists
currently enrolled in an ophthalmology residency pro
gram or fellowship.
AAOE membership includes approximately 5,700 office
administrators, managers, physicians in training, and
physicians.
Issuance FREQUENCY: 12 times a year
ISSUE DATE: First of the month
MAILING DATE & CLASS: 25th of the preceding month,
second class
AVERAGE CIRCULATION: 23,500 (see page 10 for details)
Advertising ACCEPTANCE AND COPY RESTRICTIONS: Subject to
approval by the Academy
PLACEMENT POLICY: Interspersed
2 2021 e y e n e t media kit
INVEST WHERE IT COUNTS
EyeNet = Value
When the question is: “How does our brand maximize return on
News in Review C O M M E N TA R Y A N D P E R S P E C T I V E
investment?” keep in mind these top four reasons to make EyeNet
the cornerstone of your marketing campaign.
PEDIATRICS tional age (GA) of
New ROP Screening 30 weeks or less.
The new G-ROP
Criteria Validated guidelines use six
criteria, any one of
NEW CRITERIA FOR EXAMINING which leads to an
premature infants for retinopathy of examination for
prematurity (ROP) have been found to ROP. These criteria
be more sensitive and specific than cur- include a BW of
rent screening guidelines.1 The study less than 1,051 g;
group known as G-ROP reaffirmed that a GA of less than ROP. The now validated G-ROP criteria include measures of
the new criteria are 100% sensitive for 28 weeks; three slow growth as well as birth weight and gestational age.
predicting type 1 ROP. Moreover, the measures of slow
new guidelines have the potential to postnatal weight gain; or the presence applies only to countries with highly
reduce the number of infants receiving of hydrocephalus. developed neonatal care systems. It is
examinations by a third. The postnatal weight gain measures not generalizable to countries in which
The new screening criteria have both capture infants with higher BW and excessive oxygen supplementation is the
clinical and cost-saving implications. older GA who develop type 1 ROP. primary cause of ROP and postnatal
Fewer at-risk babies will have to endure Weight gain is a proposed surrogate weight gain is not reliably predictive of
stressful retinal examinations in the measure for factors that result in de- ROP. Dr. Binenbaum said that each new
neonatal ICU, and those who would creased VEGF activity and poor retinal setting will require separate validation.
benefit from an examination are less vessel development. Toward a new standard. The case for
likely to slip through the cracks. Generalizability of the G-ROP adopting a new set of national guide-
1. WIDEN YOUR REACH. EyeNet’s CPM makes it the best
“We were happy that the criteria criteria. The validation study applied lines is strong, Dr. Binenbaum said. In
maintained such high sensitivity,” said the G-ROP criteria to a new cohort the pooled cohort analysis, for example,
study group chair Gil Binenbaum, MD, of premature babies (N = 3,981), who currently recommended guidelines pre-
MSCE, at the Children’s Hospital of were examined between 2015-2017 at dicted 674 of 677 type 1 cases (99.6%
Philadelphia. “Even though they were 25 of the original G-ROP hospitals and sensitivity), compared to 100% sen-
developed using data from a very large 16 new hospitals in the United States sitivity screening with the newer
value among competing publications such as EyeWorld,
cohort, there was still a chance that and Canada. G-ROP criteria.
some overfitting could have occurred In the current study, the criteria pre- “Even a 0.4% decrease in sensitivity
or that changes in neonatal care, such dicted 219 of 219 cases of type 1 ROP is not acceptable,” Dr. Binenbaum said,
as oxygen saturation targets, may have (100% sensitivity). And the percentage as this represents about 25 babies a year
resulted in changes in the character- of infants undergoing exams fell by nationally being missed and possibly
istics of infants who developed severe 35.6% (n = 1,418). In a pooled cohort going blind.
Ocular Surgery News, Ophthalmology Management, and
ROP. Fortunately, the G-ROP criteria of 11,463 infants from this study and “If the difference were reversed and
still performed well.” an earlier cohort, the criteria predicted the G-ROP criteria had the slightly low-
Gil Binenbaum, MD
Expanding the criteria to improve 677 of 677 cases of type 1 ROP (100% er sensitivity, there would be no chance
screening. Currently recommended sensitivity) and yielded a 32.5% reduc- anyone would use them to decide who
guidelines are based on birth weight tion in examinations (n = 3,730). to examine. But the situation is not re-
Ophthalmology Times.
(BW) of less than 1,501 g or a gesta- A caveat. The validation study versed. So, the argument to keep using
EYENET MAGAZINE • 19
19-21_News_F.indd 19 1/13/20 7:47 PM
1x Page
Publication Frequency Affiliation Circulation* CPM
4/C Gross*
EyeNet 12x AAO 23,500 paid $5,919 $252
Ophthalmology Times
20x None 20,076 non-paid $6,665 $255
Island Unit
Review of
12x None 21,520 non-paid N/A N/A
Ophthalmology
Ocular Surgery News
24x None 18,401 non-paid $6,610 $359
Island Unit
Ophthalmology
12x None 18,059 non-paid $7,690 $426
Management
EyeWorld 12x ASCRS 14,919 paid $7,015 $470
*Source: 2019 Media Kits and SRDS
2. IMPROVE ANNUAL MEETING BOOTH PRIORITY.
By advertising with EyeNet or any of its related publications,
you will gain Academy priority points. Overall points ulti
mately determine placement in the booth selection process
at the Academy’s annual meeting. Learn more at aao.org/
annual-meeting/exhibitor/priority-points.
3. DRAW ON THE ACADEMY’S REPUTATION. As the
official newsmagazine of the American Academy of
Ophthalmology—the premier association for ophthalmolo
gists—EyeNet content is highly regarded as a source of
reliable, nonbiased information.
4. HIT EVERY MEDIUM. With EyeNet, you’ll get packages
tailored to your budget, target audience, and timeline. Take
advantage of multiple channels to reinforce your brand,
including video, print cover tips, e-mail blasts, website
advertising, and more.
aao .org/eyenet/advertise 3
2021 EDITORIAL CALENDAR
The Best in Clinical Insights
January April before, and many were able last year, and what are the
Biosimilars. A look at The COVID Vaccine. An to implement practice ef repercussions for future
biosimilars—what they assessment of vaccine safety ficiencies that they never acquisitions of ophthal
are, how they differ from and efficacy—plus, an over would have thought possible. mology practices? EyeNet
generic drugs, and the pros view of how these vaccines Clinical Updates investigates.
and cons of their use. Plus: affect the genetic code. Glaucoma Retina l
Clinical Updates
A look at the regulatory Clinical Updates Distributed at ASCRS Comprehensive Oncology
l
process. Neuro Pediatrics November
August
l
Clinical Updates May Data Science for the Oph- (Annual Meeting issue)
Comprehensive Retina
l
Update on Cornea. EyeNet thalmologist. Understand Focus on Artificial Intelli-
delves into the latest devel ing statistical analysis in the gence. With the pace of
February
opments in cornea from ophthalmology space in the technological advance ever-
Cataract Spotlight. Re
the last few years. This 21st century is becoming in quickening, it can be chal
visiting the Spotlight on
survey puts a special em creasingly complex. EyeNet lenging to keep abreast of
Cataract session during
phasis on recent findings looks at statistical methods the realm of artificial intel
AAO 2020 Virtual, EyeNet
from the field of regenera used in the literature and in ligence. EyeNet reviews the
presents a selection of eight
tive medicine. clinical trials. latest trends and develop
challenging cases, with
ments.
commentary from the Clinical Updates Clinical Updates
presenting experts. Cataract Glaucoma
l Cataract Refractive
l Clinical Updates
Cornea Neuro Retina
l l
Clinical Updates June September
Distributed at AAO 2021,
Cornea Oncology
l
Health Care Disparities. Visual Acuity. Will the Snel New Orleans
March Racial and socioeconomic len acuity chart become a
December
Quality of Life. Patients may disparities have a profound thing of the past? Emerging
A Look Ahead. EyeNet
not complain about treat impact on access to health technology is raising the
invites several of its editorial
ment burden, but it may be care. A look at how this possibility of novel ways of
board members to discuss
greater than the ophthal plays out in glaucoma care, assessing visual acuity.
the news and trends within
mologist realizes. A look at from diagnosis to follow-up. Clinical Updates
their subspecialties from
the patient experience and Clinical Updates Cornea Oculoplastic
l
2021 and to examine these
how physicians can improve Trauma Uveitis
October
l
events for their likelihood
quality of life, benefitting July The Private Equity Land- to affect the profession of
patients and improving How COVID-19 Super- scape After COVID-19. ophthalmology.
outcomes. charged Lean Management. What did ophthalmologists Clinical Updates
Clinical Updates The pandemic forced prac learn about the private Comprehensive Interna
l
Glaucoma Refractive
l
tices to experiment like never equity model during the tional
2021 Ad and Materials Deadlines
January April July October
Ad close: December 1 Ad close: March 1 Ad close: June 1 Ad close: September 7
Materials close: December 4 Materials close: March 5 Materials close: June 4 Materials close: September 10
February May August November (AAO 2021 issue)
Ad close: January 4 Ad close: April 5 Ad close: July 6 Ad close: September 27
Materials close: January 8 Materials close: April 9 Materials close: July 9 Materials close: October 1
March June September December
Ad close: February 1 Ad close: May 3 Ad close: August 2 Ad close: November 1
Materials close: February 5 Materials close: May 7 Materials close: August 6 Materials close: November 5
4 2021 e y e n e t media kit
YOUR 2021 MARKETING PLAN
EyeNet Tops the Charts
EyeNet Delivers!
KANTAR®, an independent, third-party market #1 in Average Page Exposures
research firm, conducts annual readership surveys
37% EyeNet
to study the reading habits of U.S. ophthalmologists.
35% Publication A
2020’s findings show the following rankings.
33% Publication B
Among all ophthalmic publications, EyeNet is:
32% Publication C
#1 in Average Page Exposures. In EyeNet, your
24% Publication D
ad pages will have greater visibility than in any other
ophthalmic publication. 21% Publication E
18% Publication F
Among comprehensive ophthalmic trade publications,
EyeNet is:
#1 in Total Readers. EyeNet has broad reach! 72% #1 in High Readers. EyeNet has the most dedicated readers
of U.S. ophthalmologists say that they read EyeNet. for the 10th year in a row.
#1 in Average Issue Readers. More ophthalmolo
gists are likely to read EyeNet than its competitors. SOURCE: KANTAR® 2020 Eyecare Readership Study.
The Newsmagazine With the Most Receptive Readers
Among comprehensive ophthalmic trade publications, EyeNet delivers the readers you most want to reach. EyeNet is #1 in
Average Page Exposures, #1 in Average Issue Readers, and #1 in High Readers among the following groups:
Early drug adopters. Reach the ophthalmologists who doctors who need to purchase more equipment more
are most likely to update their prescription patterns. often.
Those who see medical sales representatives at least Those who write more than 50 prescriptions per
1x week. Extend your messaging and improve its “effective week. Be seen by highly productive prescribers, prolific
frequency” by putting your product on EyeNet’s pages. Rx writers.
Those whose annual revenue exceeds $500,000. High-volume practices (126+ patients/week). Get
Put your products in front of the doctors who are best your message out to the ophthalmologists most likely to
positioned to spend. need your product or service for patient care.
Those for whom ophthalmic surgery is at least
26% of practice. Develop a loyal customer base of those SOURCE: KANTAR® 2020 Eyecare Readership Study.
DEFINITIONS OF TERMS
Average issue readers: Percent of ophthalmologists who read any given LET US CREATE YOUR CAMPAIGN NOW.
issue of the publication—weighted by frequency with which they read.
Contact M.J. Mrvica Associates
Average page exposures: Percent of ophthalmologists likely to see a
856-768-9360
page in an average issue of the publication—weighted by frequency
and thoroughness of reading habits. mjmrvica@mrvica.com
High readers: Percent of ophthalmologists who report reading the
magazine both frequently and thoroughly.
Total readers: Percent of ophthalmologists who report reading the
publication.
aao .org/eyenet/advertise 5
YOUR 2021 MARKETING PLAN
Create an All-Encompassing,
Multiplatform Campaign
With EyeNet Magazine at the center AAO 2021 Opportunities
of your marketing plan, you are AAO 2021 DAILY. EyeNet’s clinical e-newsletter is reported
for four days in New Orleans to keep ophthalmologists
guaranteed a loyal and avid reader on top of news from Subspecialty Day and AAO 2021. It
is emailed nightly to more than 70,000 recipients and
base. Build out from that core with posted to aao.org/eyenet for double exposure.
EyeNet’s satellite offerings: AAO
AAO 2021 NEWS. The Academy’s convention tabloid
2021 print and electronic publica provides extensive meeting news and information. There
are two editions—one distributed on Friday, the other on
tions, custom supplements offered Sunday—displayed in high-visibility locations throughout
the hall. Your ad will appear in both editions.
throughout the year, educational
“BEST OF” SELECTIONS. Each edition recaps the
events, and digital opportunities important discoveries, issues, and trends in a subspecialty.
to engage your audience whenever Cornea, Glaucoma, and Retina editions are distributed at
Subspecialty Day, while Refractive-Cataract is distributed
and however they choose to read at both Subspecialty Day and the Spotlight on Cataract
Surgery session.
the magazine.
DESTINATION SERIES. AAO 2021 attendees turn to this
six-part series in EyeNet for deadlines, event previews,
Personalities (p. 4-9) Pandemic of the Past (p. 10) New Products (p. 13-14) And More.
l l l
interviews, sneak peeks, and more (June through
EyeNet
®
November).
AAO 2020 News
EYENET CORPORATE EVENTS. Take your hour-long
T H E V I RT UA L M E E T I N G : N OV. 13 -1 5
Don’t Miss the
Insiders’ Guide to
Subspecialty Day
message directly to ophthalmologists during lunch in
New Orleans. You develop the program, EyeNet handles
EyeNet® the marketing and logistics.
Corporate
Lunches
EXHIBITOR GUIDE. The ONLY printed exhibitor list for
Presented by
Regeneron
Pharmaceuticals
and designed
Saturday, Nov. 14 AAO 2021. Showcase your product with an upgraded
listing.
for U.S. retina A Treatment Option for
specialists.
Wet Age-Related Macular
Degeneration, Diabetic
The Venetian Macular Edema, and
Las Vegas Diabetic Retinopathy
Marcello, 4th Floor
Speakers: Jordana G. Fein, MD, MS,
Check-in and
and John D. Pitcher, MD
Lunch Pick-up
12:00-12:30 p.m.
Lunches are provided
on a first-come basis.
Program
12:30-1:30 p.m.
00_AN_Cover_F.indd 1 9/25/20 11:35 AM
AAO 2020 NEWS
These programs are non-CME and are developed
independently by industry. They are not affiliated with
the official program of AAO 2020 or Subspecialty Day.
By attending a lunch, you may be subject to reporting
under the Open Payments Program (Sunshine Act).
CORPORATE LUNCHES
EyeNet
Selections
Glaucoma 2020
Recent Articles From
EyeNet® Magazine
Exhibitor
Guide
and Hall Map
Presented by EyeNet® Magazine
00_SG_Cover_F.indd 1 8/13/20 8:11 PM
Where All of
BEST OF GLAUCOMA Ophthalmology Meets®
EXHIBITOR GUIDE
6 2021 e y e n e t media kit
YOUR 2021 MARKETING PLAN
Year-Round Opportunities Spotlight on Digital
COVER TIP ADVERTISING. Showcase your brand front eTOC. This monthly email blast provides all Academy
and center on EyeNet’s cover. Ship preprinted tips or send members with on-the-go highlights of EyeNet print
a high-resolution, press-ready PDF for EyeNet to print. content. With approximately 23,500 recipients and
a 35% open rate, it offers prime positioning.
INDUSTRY-SPONSORED SUPPLEMENTS. Tell the full
story of your products or services to ophthalmologists RETINA EXPRESS. This monthly email blast for retina
through a supplement polybagged with the monthly issue. specialists and comprehensive ophthalmologists (9,500
Develop your own content and design your own cover circulation) contains links to retina-related content from
and layout—or use the modified EyeNet design template around the Academy. With a 39% open rate, you will
provided by the Academy. effectively deliver content straight to your target audience.
MIPS MANUAL 2021: A PRIMER AND REFERENCE. WEBSITE BANNERS. Multiple sizes are available (all are
This booklet opens with a quick overview before taking run-of-site): leaderboards, skyscrapers, and boxes. The
a detailed, deeper dive into the regulations. It includes website averages 255,000 views monthly, with readers
listings for scores of MIPS measures and activities, making spending an average of seven minutes on each page.
it a valued reference. (Posted online ahead of print.)
SPOTLIGHT ADVERTORIAL. Your image and copy is
OTHER SUPPLEMENTS. Got a topic in mind? EyeNet can featured on a dedicated page on aao.org/eyenet. Callouts
work with your team to develop supplements in your area and links provide extra exposure. This page averages 200
of interest. visits per month, with each guest staying for approximately
four minutes, indicating a high level of engagement with
advertorial content.
EyeNet
®
SUPPLEMENT
MIPS 2020:
A Primer and
Reference
Published May 2020
Who Is Your MIPS Point Person, and
Who Is Backup? Make Sure They Have
This Ophthalmology-Specific Guide.
01_MIPS_COVER_F.indd 1 4/3/20 4:36 PM
MIPS Supplement
eTOC Retina Express
aao.org/eyenet
aao .org/eyenet/advertise 7
MECHANICAL REQUIREMENTS
Page Unit Non-Bleed Bleed
Spread (two facing pages) 15" x 10" 16 1/2" x 11 1 ⁄ 8 "
Full page 7" x 10" 8 3 ⁄ 8 " x 11 1 ⁄ 8 "
1/2 page (horizontal) 7" x 4 3/4" 8 3 ⁄ 8 " x 5 1/2"
1/2 page (vertical) 3 1/4" x 10" 4 1/4" x 11 1 ⁄ 8 "
2/3 page (vertical) 4 1/2" x 10" 5 3⁄8" x 11 1 ⁄ 8 "
1/4 page 3 1/4" x 4 3/4" N/A
Trim
EyeNet Trim Size (Page): 8 1/8" x 10 7/8"
EyeNet Trim Size (Spread): 16 1/4" x 10 7/8"
Live Matter: Bleed sizes include 1/8" trim from outside, bottom, top,
and gutter. Keep live matter 1/2" from trim size of page.
Production Specifications ded in art files. If submitting an InDesign docu
ment (CS4 or greater), you must supply all fonts
EyeNet Magazine Trim Size and art files. Line art should be scanned at 600
8.125” x 10.875” dpi. Images (TIFF or EPS) should be at least 266
Paper Stock dpi and saved in CMYK mode.
Inside Pages: 50 lb. text Send the following:
Cover: 70 lb. cover with varnish • Ad file (high-resolution PDF or native files).
Binding • Any supporting graphics that are incorporated
Perfect Bound in the ad (e.g., logo file, images).
• Screen and printer fonts. Fonts must still be
Digital Ad Requirements included even if the ad is saved as an EPS file.
High-resolution PDF is the preferred file format. Reproduction Requirements
These flattened files (PDF/X-1a:2001) should be
created using Adobe Acrobat Distiller 4.05 (or In order to ensure reproduction accuracy,
greater) or exported from Quark XPress or InDe color ads must be accompanied by a proof
sign using the PDF/X-1a:2001 setting. All graphics prepared according to SWOP standards. If
and fonts must be embedded. Spot colors, RGB, a SWOP-certified proof is not supplied, the
EyeNet and LAB colors should be converted to CMYK publisher cannot assume responsibility for
Advertising before creating the PDF. All trim and registration correct reproduction of color.
Materials marks must appear outside the bleed area (1/8 The Academy is not responsible for and
inch from trim). Scanned images must be saved reserves the right to reject materials that do
as high resolution (at least 266 dpi) in TIFF or not comply with mechanical requirements.
EPS format. Maximum ink density should not
exceed 300%. Insert Requirements
TIFF and EPS files created with Illustrator or Average run is 23,500. Contact M.J. Mrvica
Photoshop are also acceptable. Supply both Associates for further details.
printer and screen fonts, including fonts embed
8 2021 e y e n e t media kit
2021 EYENET ADVERTISING RATES
Black-and-White Rates
Frequency Full Page 2/3 Page 1/2 Page 1/4 Page
1x $3,550 $2,945 $2,300 $1,420
3x $3,480 $2,890 $2,260 $1,390
6x $3,375 $2,800 $2,190 $1,350
12x $3,300 $2,740 $2,150 $1,320
18x $3,195 $2,650 $2,080 $1,280
24x $3,160 $2,625 $2,055 $1,265
36x $3,090 $2,565 $2,010 $1,235
Color Rates
Frequency Full Page 2/3 Page 1/2 Page 1/4 Page
1x $6,215 $5,590 $4,970 $4,040
3x $6,090 $5,480 $4,870 $3,960
6x $5,905 $5,315 $4,720 $3,840
12x $5,780 $5,200 $4,625 $3,760
18x $5,595 $5,035 $4,475 $3,635
24x $5,530 $4,980 $4,425 $3,595
36x $5,410 $4,865 $4,325 $3,515
Premium Positions and Inserts
Cover and Other Special Rates Inserts
COVER 2: 35% over earned black-and-white rate. 2-PAGE INSERT: Two times earned black-and-
COVER 3: 20% over earned black-and-white rate. white rate.
COVER 4: 50% over earned black-and-white rate. 4-PAGE INSERT: Four times earned black-and-
TABLE OF CONTENTS: 15% over earned black- white rate.
and-white rate. OTHER ITEMS: Split runs available, but pricing
OPPOSITE EDITORIAL BOARD: 10% over earned will remain the same.
black-and-white rate.
OPPOSITE JOURNAL HIGHLIGHTS: 10% over
earned black-and-white rate.
COVER TIPS: Call for availability and pricing.
EyeNet
®
Advertising Incentives EyeNet’s Advertising AUGUST 2020
Sales Firm Targeting
Astigmatism
CUSTOM ADVERTISING PACKAGE: A Stepwise Approach
for Cataract Patients
Contact M.J. Mrvica Associates for details. M.J. Mrvica Associates, Inc.
2 West Taunton Ave.
Agency Information Berlin, NJ 08009
Tel. +1.856.768.9360
AGENCY COMMISSION: 15% allowed to agencies Fax +1.856.753.0064 Open Globe Injury
Assessment and Pre-Op Management
of record, with billing to the agency. In-house Cornea Donor Tissue
How Old Is Too Old?
Mark Mrvica, Kelly Miller OPINION
agencies are acceptable.
Rubber Bullets and Responsibilities
mjmrvica@mrvica.com
AGENCY RESPONSIBILITY: Payment for all ad
01_Cover_F.indd 1 7/7/20 7:54 PM
vertising ordered and published.
EARNED RATES: Earned rates are based on
the total number of insertions (full or fractional
pages) placed within a 12-month period.
Space purchased by a parent company and its
subsidiaries is combined.
aao .org/eyenet/advertise 9
CIRCULATION PROFILE
RETINA
EyeNet Circulation Profile*
Active U.S. Academy Members................................. 18,541
CLINICAL UPDATE
Vitreoretinal Surgery for COVID–19
Positive Patients
U.S. Academy Members in Training..........................2,278
D
uring this pandemic, we are
continuing to do our best to
safely provide optimal care for
vision-threatening conditions, regard-
institutional policies, risks
to surgeon and staff, and the
office workflow.
Professional guidelines.
U.S. AAOE Members (nonphysician)........................2,632
less of a patient’s COVID-19 status, said
Both the Academy and the
Durga Borkar, MD, at Duke University American Society of Retina
School of Medicine in Durham, North Specialists (ASRS) provide
Carolina. general guidelines for oph-
But what if the patient is infected thalmologists considering
with SARS-CoV-2 and you need to per- surgery, said Dr. Holland,
form vitreoretinal surgery? How does at the Stein Eye Institute,
American Academy of Ophthalmology Members
this change your practices? University of California, in
“You want to delay as long as possible
Los Angeles. RETINAL DETACHMENT. Urgent and nonelective
to avoid operating on someone who These guidelines cover surgeries for conditions such as retinal detach-
could be actively shedding the virus, everything from personal ment require extreme care in patients who are
but not so long as to produce negative protective equipment (PPE) positive for COVID-19.
visual consequences,” said Benjamin recommendations and risk
Self-Reported Subspecialty Focus*
Reiss, MD, at the Retina Institute of assessments to specific protocols regard- ditional policies for handling COVID-19
Washington in Renton. ing patient care. They leave room for
1,2
positive patients, which surgeons need
Both Drs. Borkar and Reiss recently discretion, said both Drs. Holland and to follow, said Dr. Borkar. This requires
performed retina procedures on patientsReiss. “That’s partly because doctors a conversation with the hospital and
who tested positive for SARS-CoV-2. must consider many specific details, OR staff to determine whether a team,
(primary and secondary)
Together with Gary N. Holland, MD such as whether or not a patient is room, and supplies are available, said
—who is one of three ophthalmolo- functionally monocular,” said Dr. Reiss. Dr. Reiss.
gists curating clinical content for the Discretion is also called for because The patient’s condition. “Many con-
Academy’s aao.org/coronavirus web each region and institution varies in ditions we treat in our retina subspe-
pages—they share their insights on risk level and access to PPE, equipment, cialty are urgent and nonelective,” said
beds, and staff. “Not all places can ad-
how to balance the surgical needs of the Dr. Reiss. This includes conditions such
here to the ideal,” said Dr. Holland.
patient with the safety of all concerned. as retained lens fragments, endophthal-
Administration/Organization Leadership................... 124
“Also, there’s a lot we still don’t know, mitis, retinal detachment, acute vitre-
Factors to Consider Before for example, whether or not procedures ous hemorrhage of unknown etiology,
Deciding on Surgery such as retina surgery are aerosol gen- and flashes and floaters.
© American Academy of Ophthalmology.
Deciding whether or not to operate on erating. Recommendations may need to Dr. Borkar said that three factors
a COVID–19 positive patient involves change as we gather more information.” help influence her decision in an urgent
a multifaceted calculus: It considers Institutional policies. Because of case: 1) The patient is systemically
not only the patient’s specific condi- regional and institutional differences, well enough to safely undergo surgery.
Cataract................................................................................6,136
tion but also professional guidelines, hospitals have developed their own ad- 2) The patient has good visual poten-
tial. 3) It’s likely that taking the patient
to the OR will provide a superior stan-
BY ANNIE STUART, CONTRIBUTING WRITER, INTERVIEWING DURGA dard of care over an in-office proce-
BORKAR, MD, GARY N. HOLLAND, MD, AND BENJAMIN REISS, MD. dure. Of course, she added, this deci-
Comprehensive Ophthalmology................................ 7,474
EYENET MAGAZINE • 27
27-29_CUret_F.indd 27 6/4/20 7:06 AM
Cornea/External Disease............................................. 2,087
Glaucoma............................................................................2,248
Destination AAO 2020 G E T R E A DY F O R L A S V E G A S • PA R T 1 O F 6
International Ophthalmology............................................53
Medical Education.................................................................59
WELCOME
Looking Forward to
Las Vegas
Neuro-Ophthalmology......................................................438
Ocular Oncology.................................................................. 182
Now is the time to start preparing for
the Academy’s annual meeting, the
year’s best opportunity to learn from
leaders in the field, discuss current
topics in medicine, connect with col-
leagues, and explore the city.
Oculofacial Plastics/Reconstructive..........................1,262
What about COVID-19? Of course,
given the current crisis, the Academy SKILLS TRANSFER LABS. The Skills Transfer labs are an important opportunity for
is actively monitoring developments physicians to learn the most up-to-date techniques. Tickets, available for members
and soliciting input from public health starting June 17, are required for Skills Transfer labs.
authorities, as the health and safety of
meeting participants and attendees is of REGISTRATION Q: What’s new for AAO 2020?
utmost importance. At this time, AAO A: There is increased emphasis on
Ophthalmic Genetics............................................................59
2020 is still scheduled for November as New! June—Not April—for making courses and materials more
planned. The Academy looks forward AAO 2020 Registration and interactive. Especially with the newer
to the passing of this pandemic and a Hotel Booking generation of attendees, we’re finding
visionary meeting in Las Vegas. The Academy has announced that AAO that they’re learning more through
When to be there. AAO 2020 runs 2020 registration and hotel reservations engagement than by sitting in a lecture,
Nov. 14-17 and is preceded by Subspe- will now open June 17 for members and we want to be sure the Academy
Ophthalmic Pathology.........................................................85
cialty Day meetings, held Nov. 13-14. and July 8 for nonmembers. is providing that. We’re going to have
You can also attend the American Acad- In the meantime, avoid scams. Sev- more of the interactive poster sessions
emy of Ophthalmic Executives (AAOE) eral fraudulent companies pretending to promote more discussion and small
Practice Management Program Nov. to be associated with the Academy and group learning.
13-17, and the American Society AAO 2020 may appear in web searches Q: What kind of trends have you
of Ophthalmic Registered Nurses or may have already contacted you via seen in association meetings?
(ASORN) Program Nov. 13-14. email. A: In general, meetings are getting
Other........................................................................................ 299
How to prepare. Over the next six Learn how to spot a fraud, visit aao. bigger, and the Academy is no exception.
months, this Destination AAO 2020 org/registration#fraud. Some of the feedback that we have been
section will guide you through dead- getting—at least from newer attendees
lines, preview the scientific program, WHAT’S TO COME —is that there are so many excellent
and highlight key events. sessions to choose from that it can be
Dr. Jeng’s Insider Perspective a challenge to decide what’s a priority.
Pediatric Ophthalmology
Bennie H. Jeng, MD, is serving his first With this in mind, the Mobile Meeting
year as the Chair of the Annual Meeting Guide is constantly being improved to
Program Committee. Here, Dr. Jeng offer a better navigation experience.
gives a preview of what’s to come in The Academy meeting is also a
Las Vegas. convener of all the different subspecial-
and Strabismus............................................................... 1,147
EYENET MAGAZINE • 61
61-63_Dest_F.indd 61 4/14/20 9:53 AM
Refractive Surgery..........................................................2,000
Retina: Medical Only.......................................................... 705
Journal Highlights
Retina/Vitreous: Medical and Surgery......................2,961
N E W F I N D I N G S F R O M T H E P E E R - R E V I E W E D L I T E R AT U R E
Ophthalmology
Selected by Stephen D. McLeod, MD
events were mon-
itored throughout
progression than the thin-
ning of either layer alone.
Volume 127 | Number 10 | October 2020
Uveitis/Immunology.......................................................... 432
Volume 127 | Number 10 | pp. XXX–XXX
Elsevier | ISSN 0161-6420
the study. They found that evaluating
Quarterly Abicipar Is Not Inferi- At week 52, these layers together helped
Vision Rehab............................................................................27
or to Monthly Ranibizumab neither abicipar identify disease progression
October 2020 regimen was infe- in eyes that was not captured
ERT
rior to ranibizu- by looking at either layer
DV
A
Abicipar is a designed ankyrin-repeat mab in the prima- separately. Their technique
RT
OPHTHALMOLOGY
SE
protein that binds VEGF with higher ry or secondary also boosted the ability to
IN
affinity and longer intraocular per- efficacy measures. detect visual loss.
sistence than ranibizumab. Kunimoto The proportion In this prospective study,
et al. compared abicipar administered of patients with the authors monitored 440
October 2020
every eight or 12 weeks to ranibizumab stable vision was eyes of patients with glau-
given at four-week intervals in patients
OPHTHA_v127_i10_COVER.indd 1
93.2% in the ab- coma and 98 unaffected
6/19/2020 4:19:32 AM
with treatment-naive neovascular age- icipar Q8 group, control eyes at intervals of
related macular degeneration (AMD). 91.3% in the abicipar Q12 group, and approximately four months for at least
The treatments were comparable in 95.8% in the ranibizumab group. Mean three years. They used swept-source
terms of vision stability; however, the BCVA gains from baseline were 7.5, optical coherence tomography (SS-
rate of intraocular inflammation was 6.4, and 8.4 letters, respectively. The OCT) with a wide field (12 × 9 mm2)
higher with abicipar. mean decrease in CRT was similar for to measure RNFL thickness over the
* SOURCE: American Academy of Ophthalmology Membership Data,
For their study, the authors pooled all groups. Although the adverse event parapapillary region, GCIPL thickness
52-week results of two randomized rates were similar, intraocular inflam- over the macula, or the thickness of
phase 3 trials (CEDAR and SEQUOIA), mation was more common in patients both layers during the same scan. Thin-
which had identical protocols. Patients who received abicipar (15% vs. 0.3%). ning was determined from serial SS-
(n = 1,888) had been assigned to one Because of this, study discontinuation OCT data by trend-based progression
August 2020.
of three groups. The Q8 group received and severe vision loss occurred more analysis (TPA). False-positive results
2 mg of abicipar initially (baseline, frequently with abicipar. Modified drug- were defined as thinning detected by
week 4, week 8) and every eight weeks purification strategies are being explored TPA in nonglaucomatous control eyes.
thereafter. Similarly, the Q12 group to reduce the risk of intraocular inflam- Anatomic findings were compared with
had 2-mg loading doses of abicipar mation with abicipar. visual field (VF) results over time.
(baseline, week 4, week 12) followed by In the glaucoma group, 127 eyes
the same dose at 12-week intervals. The Assessing RNFL Plus GCIPL (28.9%) had progressive thinning of
ranibizumab group received standard Improves Detection of Glaucoma the combined RNFL/GCIPL. Only 74
dosing of 0.5 mg every four weeks. Progression eyes (16.8%) had progression of the
The main outcome measure was October 2020 RNFL alone, and just 26 eyes (5.9%)
the proportion of patients with stable had progression of the GCIPL alone.
vision, defined as best-corrected visual Wu et al. considered that progressive Thinning of either single layer usually
acuity (BCVA) decline of less than 15 thinning of the retinal nerve fiber layer was noted later than thinning of the
letters from baseline. Secondary end- (RNFL) and the ganglion cell inner combined RNFL/GCIPL; the median
points were mean changes in BCVA and plexiform layer (GCIPL) may be a lag time was about four months. With
central retinal thickness (CRT). Adverse more reliable surrogate of glaucoma the false-positive rate controlled at 5%,
EYENET MAGAZINE • 21
21-25_JHI_F.indd 21 9/14/20 3:34 PM
10 2021 e y e n e t media kitADVERTISING POLICY
Personalities (p. 4-9) Pandemic of the Past (p. 10) New Products (p. 13-14) And More.
l l l
The following terms and conditions shall be incorporated by reference
EyeNet
®
into all insertion orders submitted by Advertiser or its advertising agen AAO 2020 News
cy (collectively, “Advertiser”) to the American Academy of Ophthalmol
T H E V I RT UA L M E E T I N G : N OV. 13 -1 5
Don’t Miss the
Insiders’ Guide to
ogy, EyeNet, and/or M.J. Mrvica Associates (collectively, “Publisher”) for Subspecialty Day
all EyeNet publications, including but not limited to EyeNet Magazine,
EyeNet’s AAO 2021 News, EyeNet Best of, EyeNet’s Exhibitor Guide,
EyeNet’s AAO 2021 Daily, EyeNet’s Destination AAO 2021, EyeNet’s
Home Page, EyeNet’s Digital Edition, EyeNet Supplements, EyeNet
Online Exclusives, EyeNet E-Newsletters, EyeNet Retina Express, and
EyeNet reprints:
00_AN_Cover_F.indd 1 9/25/20 11:35 AM
1. Only Publisher may accept advertising. 10. Publisher shall have no liability for error in the Advertiser
2. Invoices are rendered on the publication date of each issue Index.
and are due and payable upon receipt of invoice. 11. Advertisements not received by the Publisher by ad close
3. Publisher shall have the right to hold advertiser and/or date will not be entitled to revisions or approval by Adver
advertising agency jointly and severally liable for such tiser.
monies as are due and payable to Publisher for published 12. Advertiser may not make changes in orders after the ad
advertising ordered by advertiser or its agent. close date.
4. Publisher reserves the right to reject or cancel any adver 13. Cancellations must be in writing and will not be accepted
tisement that, in Publisher’s sole opinion, Publisher deter after the ad close date.
mines is not in keeping with the publication’s standards or 14. Advertiser will be charged for any artwork, separations,
for any other reason, even if advertising has been published halftone, shipping, or typography provided by the Publisher.
previously by Publisher. 15. Under no circumstances shall Publisher be liable to Adver
5. Advertiser assumes all liability for all content (including tiser for any indirect, special, or consequential damages
text, illustrations, representations, copyright, etc.) for pub (including, without limitation, loss of profit or impairment
lished advertisements and further indemnifies and holds of goodwill). Under no circumstances shall the Publisher’s
harmless Publisher for any claims against Publisher arising total liability to any Advertiser exceed the invoiced cost of
from the advertisement. the advertisement.
6. Any attempt to simulate the publication’s format or content 16. Publisher will hold Advertiser’s materials for a maximum of
is not permitted, and the Publisher reserves the right to one year from last issue date. Advertiser must arrange for
place the word “advertisement” with any copy that, in the the disposition of artwork, proofs, or digital materials prior
Publisher’s sole opinion, resembles or simulates editorial to that time; otherwise, materials will be destroyed. All re
content. quests regarding disposition of Advertiser’s materials shall
7. Terms and conditions are subject to change by Publisher be in writing.
without notice. 17. No conditions other than those set forth in this Media Kit
8. Positioning of advertisements is at the discretion of the shall be binding on the Publisher unless specifically agreed
Publisher except where specific positions are contracted to, in writing, between Publisher and Advertiser. Publisher
for or agreed to, in writing, between Publisher and Adver will not be bound by conditions printed or appearing on or
tiser. der blanks or copy instructions that conflict with provisions
9. Publisher shall not be liable for any costs or damages if of this Media Kit.
for any reason it fails to publish an advertisement or if the
advertisement is misplaced or mispositioned.
aao .org/eyenet/advertise 11EyeNet
®
NOVEMBER 2020
AI in
the Clinic
Eye Care’s Pioneering
Use of Big Data
Giant Cell Arteritis
Diagnosis and Advances in Treatment
Chronic Unilateral Conjunctivitis
Key Questions to Ask
AAO 2020 Virtual
Original Papers (p. 17) and
Last-Minute Checklist (p. 59)
01_Cover_F.indd 1 10/12/20 2:24 PM
EyeNet Magazine
655 Beach Street
San Francisco, CA 94109
Tel. +1.415.561.8500
Fax +1.415.561.8575
eyenet@aao.org
Advertising and
Reprint Sales Firm
M.J. Mrvica Associates, Inc.
2 West Taunton Avenue
Berlin, NJ 08009
Tel. +1.856.768.9360
Fax +1.856.753.0064
mjmrvica@mrvica.comYou can also read
